Drug
Bexarotene clinical trials
Also written Targretin and LGD1069.
- studies test it
- 36
- open now
- 1
- in phase 3
- 6
- first study started
- 1998
Keep track of what changes. Save the Bexarotene studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Combined with it in one product
Studies by the year they started
33 studies that test it; most in 2001 (5)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2001 | 5 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 15
- Phase 2
- 18
- Phase 3
- 6
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 28
Memorial Sloan Kettering Cancer Center (3) · Dartmouth-Hitchcock Medical Center (2) · M.D. Anderson Cancer Center (2) · Abramson Cancer Center at Penn Medicine (2) · Ligand Pharmaceuticals (2) · Eisai Inc. (2) · Beersheva Mental Health Center (2) · Stanford University (1)
Often tested with
Tested in the same studies.
Erlotinib (3) · Gefitinib (1) · Pralatrexate (1) · Rosiglitazone (1) · Gemcitabine (1) · Decitabine (1) · Carboplatin (1) · Paclitaxel (1)
Studies
Open first, then newest update. How each study uses Bexarotene is read from its arms, and is right about nine times in ten.
Testing it · 36
- A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesRecruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT05296304Written as Bexarotene
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerCompletedPhase 1/2Stanford UniversityNCT00238628Written as Bexarotene
- The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCCompletedPhase 1National Cancer Centre, SingaporeNCT04664829Written as Bexarotene
- Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive TractCompletedPhase 1Dartmouth-Hitchcock Medical CenterNCT01116622Written as Bexarotene (Targretin®)
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerCompletedPhase 1National Cancer Institute (NCI)NCT03323658Written as Bexarotene
- Phase II Study of Bexarotene in Patients With Acute Myeloid LeukemiaTerminatedPhase 2Abramson Cancer Center at Penn MedicineNCT00615784Written as Bexarotene
- BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedPhase 2M.D. Anderson Cancer CenterNCT00411632Written as Bexarotene
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedPhase 1Acrotech Biopharma Inc.NCT01134341Written as Bexarotene Capsules
- Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)CompletedPhase 4Bausch Health Americas, Inc.NCT01007448Written as Bexarotene
- A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung CancerTerminatedPhase 1/2Dartmouth-Hitchcock Medical CenterNCT00153842Written as Bexarotene (targretin)
- Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung CancerCompletedPhase 2Konstantin DragnevNCT00125359Written as erlotinib and bexarotene
- Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00425477Written as bexarotene
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00255801Written as Targretin® (bexarotene)
- Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis FungoidesTerminatedPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT00056056Written as bexarotene
- Phase I Study of CS-7017 and BexaroteneTerminatedPhase 1Georgetown UniversityNCT01504490Written as CS-7017 and Bexarotene
- Study of Bexarotene in Patients With Acute Myeloid LeukemiaCompletedPhase 1Abramson Cancer Center at Penn MedicineNCT00316030Written as Bexarotene
- Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLCompletedPhase 2Vanderbilt UniversityNCT00178841Written as Rosiglitazone and Bexarotene
- Bexarotene Amyloid Treatment for Alzheimer's DiseaseCompletedPhase 2The Cleveland ClinicNCT01782742Written as Bexarotene
- A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy SubjectsCompletedPhase 1ReXceptor, Inc.NCT02061878Written as Bexarotene
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)TerminatedPhase 1Merck Sharp & Dohme LLCNCT00127101Written as Comparator: bexarotene
See all 36 studies that test Bexarotene →
Given in every arm · 2 — Bexarotene is usual care beside what is tested
- Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.WithdrawnNot applicableCase Comprehensive Cancer CenterNCT05106192Written as Bexarotene 1% Top Gel
- Bexarotene Augmentation of Antipsychotic Treatment for Chronic SchizophreniaCompletedPhase 3Beersheva Mental Health CenterNCT00535574Written as Bexarotene (Targretin LGD1069)
As the comparator · 1 — what is tested is compared with Bexarotene
Codes
What other systems call Bexarotene · ClinicalTrials.gg INT006780
- MeSH (NLM) D000077610BexaroteneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A61RXM4375BEXAROTENEConfirmed FDA, NLM, Wikidata
- RxNorm 233272Confirmed FDA, Wikidata
- Wikidata Q418192bexaroteneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1635BexaroteneOne source FDA
- DrugBank DB00307One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077610 | Bexarotene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A61RXM4375 | BEXAROTENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 233272 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418192 | bexarotene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1635 | Bexarotene | One source FDA |
| DrugBank | DB00307 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.